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ABSTRACT
An enhancer within intron 1 of the amyloid precursor
protein gene (APPb) of zebrafish is identified
functionally using a novel approach. Bacterial artifi-
cial chromosomes (BACs) were retrofitted with
enhancer traps, and expressed as transgenes in
zebrafish. Expression from both transient assays
and stable lines were used for analysis. Although
the enhancer was active in specific nonneural cells
of the notochord when placed with APPb gene pro-
moter proximal elements its function was restricted
to, and absolutely required for, specific expression
in neurons when juxtaposed with additional far-
upstream promoter elements of the gene. We
demonstrate that expression of green fluorescent
protein fluorescence resembling the tissue distribu-
tion of APPb mRNA requires both the intron 1
enhancer and ~28kb of DNA upstream of the gene.
The results indicate that tissue-specificity of an iso-
lated enhancer may be quite different from that in
the context of its own gene. Using this enhancer and
upstream sequence, polymorphic variants of APPb
can now more closely recapitulate the endogenous
pattern and regulation of APPb expression in animal
models for Alzheimer’s disease. The methodology
should help functionally map multiple noncontigu-
ous regulatory elements in BACs with or without
gene-coding sequences.
INTRODUCTION
About two-thirds of the highly conserved genome
sequence between human and other vertebrates as
divergent as the ﬁsh does not code for proteins, is
distributed throughout the genome, and mostly located
at large distances along the DNA from the start sites of
genes (1–7). Part of these conserved noncoding elements
(CNEs) plays a role in regulating gene expression, and
is believed to be essential to all vertebrate develop-
ment (2,4–6). Conservation of gene regulatory function
has also been demonstrated recently in the absence of
sequence similarity (8), suggesting that structural features
of DNA can be preserved despite their diﬀerent sequence.
Despite these ﬁndings, tools for functionally analyzing
CNEs continue to use a ‘targeted approach’, where PCR
ampliﬁed CNE–DNA is joined to a reporter gene and
analyzed for expression either in mice or zebraﬁsh
(9,4,10). Thus ampliﬁed CNE–DNA, was either coinjected
with linear reporter DNA (5,6) or introduced as reporter
vector plasmids (4) into zebraﬁsh eggs, and analyzed
for transient expression of green ﬂuorescent protein
(GFP) ﬂuorescence. A second approach used the Tol2
transposon system that allowed CNE-reporter gene
fusions to be integrated into the germline more eﬃciently
(10). While such studies have greatly enhanced our under-
standing of CNE function, and can be scaled up, they
encounter hurdles when multiple regulatory domains
from noncontiguous DNA act in concert to regulate
expression of the gene. Diﬃculties also arise when the
noncoding regulatory DNA is not conserved across
species and thus not recognizable prior to testing. A
third approach used the traditional enhancer trap with
a pseudo-typed murine leukemia virus to infect dechorio-
nated zebraﬁsh embryos (11) to identify regulatory
sequences in a nontargeted fashion, but more importantly,
in the context of the gene and chromosome. However,
subtractive analysis requiring deletion of sequences
thought to act in combinatorial fashion with other non-
contiguous enhancing elements, remains a hurdle with
this approach. The task of functionally identifying regu-
latory DNA of either the conserved or nonconserved
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to beneﬁt most from using a ‘nontargeted’ approach that
is also unbiased. Because such regulation is often observed
over large distances along the DNA, using bacterial
artiﬁcial chromosomes (BACs) and P1-derived artiﬁcial
chromosomes (PACs) (12–14) might prove most beneﬁ-
cial, as issues of context of those regulatory modules to
the gene can be addressed simultaneously.
A novel approach that addresses several of these issues
has been developed. An enhancer trap comprising of a
basal promoter driven reporter gene, such as GFP, is
positioned at short intervals along the genomic DNA in
the BAC clone with the help of a Tn10 transposon. The set
of enhancer trap modiﬁed BACs is then introduced into
zebraﬁsh eggs, and the patterns of GFP expression used
to map cis-acting gene regulatory elements functionally
in the BAC DNA.
We have explored the role of conserved as well as
nonconserved DNA in regulating expression of the
amyloid precursor protein (APP) gene, that is central to
Alzheimer’s disease (AD), because the understanding of
its regulation remains incomplete (15–21). An enhancer
with novel properties within intron 1 of the gene has
been identiﬁed in this report using the new approach.
We demonstrate that it is required, along with  28kb
of DNA upstream of the gene, for expression of GFP
ﬂuorescence resembling the tissue distribution of APPb
mRNA in neuronal cells reported earlier (22). This
newly identiﬁed enhancer has unique characteristics of
tissue speciﬁcity: when operating with its full comple-
ment of far upstream regulatory elements, the expression
is exclusively in neurons, but its enhancing function
is restricted to the notochord when acting through its
basal promoter elements. These observations have impli-
cation for APP gene expression and, more generally, for
context-dependent function of cis-regulatory sequences
(23,24).
MATERIALS AND METHODS
Four BAC clones from the zebraﬁsh genomic library,
CH211-235E22, CH211-219P8, CH211-192O20, CH211-
43O16 designated here as BACs A, B, C and D, respec-
tively, were purchased from BAC/PAC resources,
Oakland, CA, USA. DNA fragments from the zebraﬁsh
genome are in the pTARBAC2.1 vector in these clones.
End deletions of insert DNA in the BAC clones with loxP
transposons were generated using procedures described
earlier (25,26). Procedures for DNA isolation/puriﬁcation
from BAC deletions, ﬁeld inversion gel electrophoresis
(FIGE) analysis, end sequencing of BAC deletions with
transposon-based primers have been described earlier
(27,28). Identical procedures were followed with the
BAC deletions generated with enhancer trap transposons.
DNAs from BAC clones A, B, C were used as templates to
amplify segments of DNA from intron 1 of APPb, and
they gave identical products. Primer sequences used for
amplifying APPb intron 1 enhancer were:
LF2: 50 d CACCTGAATGTGGGATTTGGTTG 30
LR4: 50 d GATAGACTCTGGCAATCTG 30
LF1: 50 d CCAAAGCATTCTTCTGAG 30
LR5: 50 d CAAGAGTCTTGGCTCCATGTG 30
Basal promoter fragments of 0.75 and 0.35kb were ampli-
ﬁed from zebraﬁsh APPb BAC DNA using the following
primers:
UF1: 50 d AGCCATATCCTGTATATAG 30
UR1: 50 d CTGTGTTCCCAAGCGCAGCAC 30
UF3: 50 d AGAGGTAGGTTGAGGCAACAATAAC 30
The PCR ampliﬁed DNA from LF2-LR4 or LF1-LR5
for the intron element (IE), or UF1-UR1 and UF3-UR1
for the basal promoter elements 0.75 and 0.35kb, respec-
tively, was cloned in pCR2.1 vector before being con-
structed into the enhancer trap transposons.
Zebrafish egginjections
Typically  20–50pg of highly puriﬁed circular BAC DNA,
prepared by the Qiagen Sciences, Maryland, USA column
procedure described earlier (28), was injected into each
egg using an injection station from World Precision
Instruments, Florida, USA and a Nikon SMZ1500 micro-
scope. The developing embryos were scored and analyzed
for GFP ﬂuorescence after 48h, using a Nikon Diaphot
Fluorescence microscope with a Nikon high pressure mer-
cury lamp as the excitation source, and photographed with
a RT Spot from Diagnostic Instruments, Michigan, USA.
RESULTS
Regulated expression of APP gene in appropriate tissue is
important for building suitable animal models for AD
because a 42-amino acid peptide expressed from the
gene is found in neuroﬁbrilatory tangles as amyloid
plaques in brains from AD patients (29). However, to
date expression of APP gene using its endogenous promo-
ter elements is unavailable (29,30). It led us to conclude
that key regulatory sequences remained unidentiﬁed,
and BACs containing the gene were used so as not to
preclude regulation from distal promoter elements.
A loxP transposon procedure to make progressive end
deletions in BACs has been used to map genetic markers
and gene regulatory elements both on a physical map of
the chromosome (27,31), as well as functionally using cell
lines or transgenic mice (32,33). An important feature of
this technology is its ease of determining exactly where
in the BAC the loxP-transposon had inserted to create
the truncation (27,28). An additional feature is the ability
to introduce reporter genes and other DNA cassettes pre-
cisely at the new end created in the large BAC clone:
sequence in front of the loxP arrowhead as shown in
Figure 1A is retained after the recombination event that
creates the deletion (note orientation of arrow refers to
directionality of loxP sequence). It is this particular fea-
ture that we have now utilized to place a basal promoter
containing GFP gene in the BAC, such that potential
regulatory elements further upstream (shown as RE-1, -2
and -3 in Figure 1A) can drive reporter gene expression
when the retroﬁtted BAC DNA is introduced into zebra-
ﬁsh as a transgene. DNA sequences +0.147 to  0.75kb
6238 Nucleic Acids Research, 2008, Vol. 36, No. 19or +0.147 to  0.35kb surrounding the transcription
initiation site of APPb comprised the basal promoter
in the enhancer trap transposons used in this study
(Figure 1B and C).
Enhancers of transcription have traditionally been
identiﬁed through transient expression of reporter genes
in small plasmids (34–39). Transient expression from an
episomal plasmid is suitable because the gene/enhancer(s)
in stably integrated DNA in cell lines are often inﬂuenced
by chromosomal regions adjoining it. This leads to
variable expression in diﬀerent lines. Thus although few
of such episomal expression studies yield insights into
transcriptional mechanisms that involve chromatin
remodeling/modiﬁcation, they appear capable of identify-
ing enhancer elements rapidly. Transcription enhancement
by CNEs has also used transient expression in zebraﬁsh
(4–6), or mice (9,24), and similar assays are used here
to identify enhancers in APPb. Stable transgenic zebraﬁsh
lines derived from our enhancer trap BACs also show
variable expression in neurons (see below). Thus,
enhancer assays used here have relied more on transient
expression, although the major conclusions derived
from these are supported by the data from germline trans-
genic ﬁsh.
Characterization ofzebrafish APPb BACs
The BAC clones (160–200kb size) used here were charac-
terized by sequencing the ends of progressive deletions
of insert DNA using transposon-based primers Seq 1 or
loxP lox511
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Figure 1. (A) Schematic representation of the methodology. A loxP-Tn10 is used to deliver a basal promoter GFP enhancer trap (indicated as BP-
EGFP on top left end of inverted triangle) into the BAC DNA, which is then expressed as a transgene. Possible upstream regulatory elements
(marked as RE-1, -2 and -3) are indicated by the colored circles/elipses. The genomic insert DNA in the BAC is ﬂanked by loxP and lox511 sites
indicated by the thick arrow and thick broken arrow, respectively. Cre-recombination of the loxP site endogenous to the BAC and the transposed
loxP site deletes the genomic DNA from the right end, thus placing at that end the EGFP enhancer trap contained in the transposon. (B) Fine
structure of APPb gene showing exons as thick vertical black bars. UE shown in blue comprises DNA segment +0.147 to  0.35kb (i.e. 0.147kb of
UTR, +0.35kb of sequence immediately upstream of APPb transcription start site, marked by the thin arrow at start of exon 1), and is part of all
enhancer trap transposons except Tn-US, Tn-10 and Tn-13, where it is +0.147 to  0.75kb. Sections of intron 1 DNA, 2–3kb in length, A–C, were
PCR ampliﬁed and tested for enhancer activity by constructing them into transposon plasmids. Fragment B, the 2.2kb intron 1 region colored dark
green and indicated as IE tested positive, while fragments A and C tested negative. Enhancer activity of fragment B was narrowed down to 1.2kb in
Tn-82. (C) Schematic drawing of Tn-US, Tn-3 and Tn-82. Note Tn-3 and Tn-82 contain the  1kb IE (dark green arrow) in opposite orientations.
The blue arrow and the light green arrow represent UE and EGFP, respectively, with the arrowheads indicating direction of reading frame. The
transposon plasmid pTnMarkerless2 has been described in (74). The UE (0.35 or 0.75kb) is ﬂanked by AscI and XmaI sites, and the IE (1.2–2.2kb,
or 2.4 and 2.7kb in various constructs) is ﬂanked by PacI sites. The size of BAC-vector DNA bands generated with Not I enzyme digests of DNA
from BAC deletions serve as a diagnostic for authentic Cre-mediated loxP–loxP recombination, and is shown to the right of each of the transposons
Tn-US, Tn-3 and Tn-82.
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genome at Ensembl (Zv7) were consistent with there
being no major rearrangements within inserts of BACs
A–D, at the resolution of  1kb of FIGE.
Noexpression from BACs deletedwith Tn-USthat carries
only0.75kbupstream sequence (UE)fused toGFP as
enhancer trap
The exon–intron structure of APPb gene is shown in
Figure 1B. LoxP transposons were constructed with
only the +0.147 to  0.75kb DNA around the transcrip-
tion initiation site of APPb [(shown as upstream element
(UE)] fused to the GFP gene, shown as Tn-US in
Figure 1C. A set of deletions in APPb BAC clone C,
ranging in insert DNA size from 20 to 90kb was made
with this transposon. A FIGE analysis of the BAC-C
deletions with Tn-US is shown in Figure 2.
Linear transposon DNA from Tn-US was ﬁrst injected
into zebraﬁsh eggs, but no ﬂuorescence was observed
(data not shown). Next, the Qiagen puriﬁed DNA
from a set of six BAC deletions made with Tn-US were
injected. No ﬂuorescence was observed (data not shown).
Location of Tn-US enhancer trap in each BAC deletion
was conﬁrmed by end sequencing. The Tn-US generated
enhancer trap BACs had up to 90kb of DNA upstream,
but no APPb-speciﬁc DNA downstream of +0.147kb of
the gene. Clearly a cis-acting sequence downstream,
critical to expression of APPb, was missing in these
BAC constructs.
Comparative genome sequence analysis inthe APPb
generegion
A cross species genome sequence pair-wise comparison of
this region was conducted. Peaks of highly conserved
DNA between zebraﬁsh and human (Figure 3, second
row), or to a lesser degree in Fugu (ﬁrst row), but not
as conspicuous in the mouse (third row), was found
within intron 1 of APPb (marked by arrowhead within
vertical broken green lines in Figure 3). The genome is
expanded 4-fold for human and mouse but compressed
2-fold for Fugu in the region analyzed in Figure 3.
Although sequence conservation within intron 1 is low
in the mouse (third row between green lines), conservation
of function might still exist (8) [see also (40,41)].
Therefore, the possibility of highly conserved (human
and Fugu with zebraﬁsh), and semi-conserved (mouse
with zebraﬁsh) regions within intron 1 enhancing expres-
sion of APPb seemed plausible, and was next tested.
TransposonDNA alone,with 3cassettes [intron 1
(IE)+GFP+0.75kbupstream sequence,UE], elicits a
specific patternof GFP expression in thenotochord of
zebrafish when injected
Being unable to express APPb with only the  0.75kb UE,
the role of semi-conserved DNA within intron 1 was
explored by incorporating these sequences in the
enhancer trap. Because transposition eﬃciency of Tn10
drops oﬀ severely with very large inserts (42), a systematic
narrowing down of the minimum essential segment
capable of enhancer activity within the  10kb intron 1
was ﬁrst identiﬁed: we generated a set of transposons
that contained diﬀerent lengths of this intron (0.8, 1.5kb
and the set of four constructs shown in Figure 4).
These Tn-DNAs were injected into zebraﬁsh embryos
and GFP expression monitored. Thus, inclusion of frag-
ments A or C (Figure 1B) did not express GFP, but frag-
ment B resulted in notochord-speciﬁc GFP expression
(Figure 4A and C).
All constructs contained the +0.147 to  0.75kb (or
+0.147 to  0.35kb for Tn-3 and Tn-82) UE and varying
lengths of intron 1 DNA ﬂanking the GFP gene. A dis-
tinct pattern of GFP ﬂuorescence in the notochord upon
injecting linear transposon plasmid DNA into eggs was
used as a preliminary assay for scoring the intron 1 dele-
tion series (Figure 4A–D). It is known that the notochord
is somewhat promiscuous to expressing a few other genes
(43), but in our experience does not confer expression to
any segment of DNA juxtaposed into the GFP cassette in
the transposon plasmid. For example, segments A or C
from intron 1 failed to induce expression of GFP (data not
shown). The 1.2-kb piece within segment B (Tn-3 and
Tn-82 in Figure 1C) was demonstrated to be both
required and suﬃcient for the speciﬁc pattern of noto-
chord expression (Figure 4). No other pattern of GFP
expression was observed in any other tissue with the
intron 1 deletion series of Tn-plasmids.
5
10
20
30
40
50
60
70
80
90
BAC-C deletions with Tn-US 
123456789
vector band in loxP
dependent deletions
kb
Figure 2. A FIGE analysis of DNA from BAC-C deletion clones gen-
erated with Tn-US. The DNA was digested with NotI enzyme before
applying to gel. Lane 1 shows a 5-kb ladder.
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as atrue enhancer
The role of orientation of intron 1 element (IE) in enhanc-
ing APPb gene expression was tested by inverting the 2.2-
kb fragment B in the transposon. Fragment B activated
expression in both orientations (indicated as Tn-13 and
Tn-10) and produced identical patterns of GFP expression
(see Figure 4A and C), indicating that the segment
behaved as a true enhancer. Opposite orientations of
this enhancer in traps, Tn-3 and Tn-82, also produced
similar results, either in transposons (Figure 4B and D)
or when integrated into BAC DNA (compare 78C and
75C, or 52C and 38C in Figures 6 and 7). No open
reading frames could be identiﬁed in the 1.2-kb minimal
enhancer. This intron 1 enhancer could not substitute
for the +0.147 to  0.75kb UE and was unable to express
GFP by itself when placed downstream of the GFP
reporter (data not shown).
The sequence of intron 1 enhancer DNA common to
Tn-3 and Tn-82 (Figure 1C) maps to zebraﬁsh chromo-
some 9 draft assembly ZFISH7:9:29144733-29145740, and
is shown in Figure 5. A truncated version, with approxi-
mately 0.8kb of this enhancer sequence (Tn-46, not
shown), does not express GFP in the notochord as eﬃ-
ciently as the 1.2kb intron 1 enhancer (data not shown).
Generating BAC deletions withenhancer traptransposons
carrying ~1.2kbintron 1enhancer (IE) and 0.35kb
upstream sequence (UE) fused to GFP
Having rescued partial activity of the APPb promoter, we
next used this minimal construct to identify additional
sequences upstream of the gene that are essential for
expression characteristic of endogenous APPb (22).
Several deletion series were generated in BACs C and D
with Tn-3 and Tn-82. A FIGE analysis of APPb BAC-C
deletions generated with Tn-3 and Tn-82 is shown in
Figure 6. Insert DNA in deletions range in size 30–
100kb. Three deletions made in BAC-D with Tn-82
were also used to complete the analysis. Locations of
enhancer trap ends in the sequence contig surrounding
APPb, mapped by BAC end sequencing (27), is shown
to scale in Figure 7B.
Approximately 60kb on either side of the APPb gene is
devoid of other genes. There is an ASMT-like expressed
sequence tag (EST) mapped  60kb upstream of APPb.
The next gene on the 50 side is NCAM2, and is  160kb
away (Figure 7B).
Patternsof GFP expression from enhancer trapBACs
carrying~1kbintron1(IE) and0.35kbupstream
sequence (UE) fused toGFP
The enhancer trap retroﬁtted BAC DNAs were injected
into zebraﬁsh eggs without linearization at 0h postfertili-
zation. Embryos were scored between 48 and 72h later
using a ﬂuorescence microscope. The pattern of expression
of GFP ﬂuorescence shown in Figure 7A and C, is repre-
sentative of the clone and derived from at least three suc-
cessful experiments. We consider an experiment successful
when the survival of embryos is between 30% and 60% of
those injected 48h prior to scoring, and positive expres-
sion occurs in at least 20% of those survived. A typical
injection used around 60–100 eggs. Although all of the
+1
APPb
Intron1
Figure 3. Comparative genome sequence analysis of the APPb gene region  30kb upstream to +0.5kb downstream with respect to the zebraﬁsh
APPb gene transcription start site. Each horizontal panel represents a pair-wise comparison of the vertebrate species with zebraﬁsh. The ﬁrst row of
peaks show a comparison of Fugu with zebraﬁsh, the second row human with zebraﬁsh and the third row compares mouse with zebraﬁsh. The
location of the transcription start site is indicated as +1 and the intron 1 interval is marked. The region of interest within intron 1 is marked by the
green vertical broken lines. Note the high degree of conservation between human and zebraﬁsh in intron 1 marked by the thick black arrow within
the green vertical lines. The orange vertical bar designating this is not prominent because this particular conservation is absent in mouse.
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GFP expression, the data for only a subset of these
clones are shown. Figure 7A shows the pattern of GFP
expression for clones 74D, 70D and 94C. In sharp
contrast to the ﬂuorescence patterns generated with the
enhancer trap transposon plasmids (Figure 4), distinct
patterns of expression speciﬁc to neuronal cells was
observed when injecting DNAs from this set of BACs.
There is a unique network pattern of GFP ﬂuorescence
in the midbrain region, and this pattern persists till
84C, as seen in Figure 7A. Bright ﬁeld images for
some of these are shown in Supplementary Figure 1.
Expression is also seen in neurons of the spinal chord
extending throughout the length of the ﬁsh in this set
(not shown). Fluorescence in neurons is indicated by the
white arrowheads. The numbers in column of Figure 7D
(left) represent injected ﬁsh with positive expression out of
100 surviving 72 hpf.
Expression speciﬁc to neurons was also observed with
80C through 75C (Figure 7A) but pattern was simpler,
with ﬂuorescence mostly along the spinal chord. BLAST
of the end sequence of 75C puts its end to be about 28kb
upstream of the transcription start site of APPb.
DNA from BACs 72C, 52C, 38C and 29C
produced no neuronal expression of GFP (Figure 7C).
Instead, all of the ﬂuorescence was restricted to just the
notochord, and is reminiscent of the pattern observed
earlier with injecting the enhancer trap transposon
plasmids Tn-10, Tn-13, Tn-3 and Tn-82 (Figure 4).
BLAST analysis places the ends of 52 and 38 to
46kb and 60kb, upstream of APPb.
Germline expression of enhancer trapBACs
Stable transgenic ﬁsh lines have been isolated from a few
of the enhancer trap BACs shown in Figure 7B, and the
results from these corroborate our ﬁndings from transient
expression. Two independent lines of germline ﬁsh were
isolated from each of the two BACs 94C and 84C. The
F1s from diﬀerent founders with the same BAC DNA
vary somewhat in their expression patterns, although
neural ﬂuorescence is seen in all of them. Expression
from two lines of 94C and 84C is displayed in
Figures 8 and 9, respectively. The yolk sac has much
higher levels of GFP ﬂuorescence between the 48 and 72
hpf window of observation in all stable lines tested.
Diﬃculty in imaging the neural ﬂuorescence against this
Tn-10 Tn-82
Tn-13 Tn-3
0.75 kb  UE GFP 2.2 kb  IE 0.35 kb  UE GFP 1.3 kb  IE
0.75 kb  UE GFP 2.2 kb IE 0.35 kb  UE GFP
AB
CD
notochord
notochord
notochord
notochord
1.2 kb  IE
Figure 4. Patterns of GFP expression observed by injecting enhancer trap transposon plasmid. A schematic of the DNA construct injected is shown
on top of each panel with the color coding and orientation of UE, GFP and IE identical to Figure 1C. Each pair comprises the ﬂuorescence and
phase contrast of the same animal. (A–D) display the result of injecting DNAs from Tn-13, Tn-3, Tn-10 and Tn-82, respectively. Location of
notochord is marked by arrow. The embryos were between 24 and 60h postfertilization when photographed. Note that expression is exclusive to the
notochord.
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copy numbers of BACs known to integrate into the germ-
line compared to small plasmids. The problem is more
severe in the head region apparently due to its proximity,
and dissipates towards the tail. At still later times, pigmen-
tation increases and interferes with imaging. The network
pattern of GFP ﬂuorescence seen in Figure 9A–C for
84C, and Figure 8C for 94C, appears to originate
from glial cells and oligodendrocytes thought to ensheathe
axons (44). These, along with the ﬂuorescence in neurons
of the lateral line, are components of the peripheral
nervous system (PNS). Fluorescence from neurons of
the lateral line, is clearly visible below the stellate cells
(marked by the successive pink arrows in Figures 8A–C
and 9A–C), and appear similar to those observed in tran-
sient expression patterns of those BACs seen earlier in
Figure 7A. Such expression patterns are not observed in
embryos that do not carry the BAC DNA in their germ-
line as seen in Figure 8D. This control embryo shown was
obtained from parents that were positive for transient
expression of GFP characteristic of the 94C expression
pattern; but which failed to transmit the BAC DNA
through the germline. Overall, the fraction of ﬁsh with
transient expression that transmitted to the next genera-
tion was slightly below 1%. A large fraction of the
transients died during the 2-week period following
injection. No >7% of the transiently expressing embryos
surviving till adulthood were found to transmit the
DNA through the germline, i.e. their eggs were GFP
positive. Additionally, over 90% of embryos from such
germline founders were found to express GFP ﬂuores-
cence. Thus, expression in neurons, from possibly both
the central nervous system (CNS) and PNS, from both
stable transgenic lines with BACs 94C and 84C sub-
stantiate some of our earlier ﬁndings with transient
expression.
Context dependence ofthe intron1enhancer
Patterns of expression shown for 74D, 70D, 94C,
92C and 84C in Figure 7A, and expression in stable
lines derived from 94C and 84C (shown in Figures 8
and 9), resemble the pattern of APPb expression reported
earlier using in situ hybridization of APPb mRNA probes
(22). One needs to take into account the diﬀerences in
signal-to-noise resolution between a sandwich assay (22),
and direct ﬂuorescence analyzed here. Importantly,
74D through 75C did not express in the notochord
(Figure 7C). Thus, including the genome context of
APPb suppressed inappropriate expression in the noto-
chord, and activated it speciﬁcally in cells where the endo-
genous APPb gene expresses. A diﬀerent type of context
dependence of GATA factor function has been reported
recently, where diﬀerent regulatory modules dictate its
activity in hematopoietic versus endothelial cells (24).
Interestingly, the context dependent APPb intron 1
enhancer sequence identiﬁed here also contains binding
sites for members of the GATA factor family; with high
scores for GATA-3 (see Supplementary Figure 2).
BioInformatic analysis oftranscription factor-binding sites
withinintron 1enhancer
BioInformatic analysis for transcription factor binding
sites was conducted for the  1kb intron 1 enhancer
DNA. The results are shown in Supplementary Figure 2.
High scores for SOX 5 and GATA 3 factor binding sites
were noted.
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Figure 6. FIGE analysis of DNA isolated from enhancer trap-modiﬁed
BAC deletions after Not I digestion. Deletions generated in BAC-C
with Tn-3 (75C, 38C and 29C) are shown in lanes 12, 19 and
20, respectively, and those with Tn-82 shown in lanes 4–11 and
13–18. All deletion clones 94C, through 29C are numbered accord-
ing to the apparent sizes of their insert DNA on FIGE, and these are
indicated directly above or below the insert DNA band. A loxP-
independent internal deletion is shown in lane 1, and its vector band
is identical to that in starting BAC-C shown in lane 3 as SB. Lanes 2
and 21 show a 5-kb ladder.
Intron-1 Enhancer Sequence in CNE of APPb gene
Assembly: ZFISH7: chr 9: position 29144733-29145740
TAAAACTAGACCACAGCACAATCCCTTTCGGTCAGTATTGTTATTACATAAGACATC
AGCAATAAAGAAAAAGATTGACCCACTGTAATTGGTTTTCACATTAGTATTGATTCAC 
GTAACACTACAGATGAATGGAATCAAGTTTGTGGGTCTTGGTACATGTGTGCTATAG
CTTTGCCATTGTTCCAAAACTGTATTTAGTTAATTTAATTCTTCAAAATTAATTAGTAA
GTCTTAAGCATGTCAAGTGCTTAAATCTGACCTCTTGTAAGTCATTATTTTCTTTCTG
ACTGGTTCAATAAAAAAGCCCCTTTAGGCTTTTTTCATTATAGGTGCCACTTGTAGG
TACTGTGCCAAAACAATCTTTGACAGTTTGCGCTGTCACCTCTTTACTGGTCACTAT
AACCACACACAAGTCATTTTGGCTGAAAGGTCCTTTGCTTTAGCTTGCTTGTAATTA
CTAAATCTGTTTTCAGTCAGCCTCCATCTGAAAAAGGCCTTTCTTTGTTTGACTGGG
AAATGTCACTGGAACATGTAAACACGGTCGGTTTTAAATTATGTTTTTGAGAGCTAC
AAAAGCTACTTCATTGATTTTGACAGCCTTCAAGATTAAGCCAGAGCTGAATGACTC
TTGAAAGCTGCACATTTCATTTTGATAGATGCATTAATGTGGATCCTGAGCTGCTAT
GACAACCTGACTGAGACACTATTTCGGGAGATTGATATTCGCAGATGATTAGCTTTC
ACCAATGGCTCAGTGGATGTCGGTGTTAAAGCATTTTGAGCACCATGGTAATTCTAT
CATAAATGTACATCTATAGCTTATGTGCAGCATACAGAATGATCTTACTACTGCAAT
GAGCTGTCGCACACATGGGTTTCCTAAAGAGCTAACTACTGTACTGCGGTCAGTGT
AATTACAGTCTTCTGTTTTTAAACTGCCATACAGCAGAGAGATGTTTTATTGCGCTTT
AACCACCAAGCTCTTTGATTAAAAGATAGATAGAAGGAAAAACAGATTGCCAGAGTC 
TATC
Figure 5. Sequence of the intron 1 enhancer of zebraﬁsh APPb gene.
Only the sequence of 1008bp common to the IEs of transposons Tn-3
and Tn-82 is shown here.
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Regulation of theAPPb gene
Several earlier reports noted the absence of a consensus
TATA box in the  30 region of the APP gene in higher
vertebrates (15,18). Although the zebraﬁsh APPb
gene promoter remains uncharacterized, regulation of
the gene from several other vertebrates had been studied
extensively (15–21). As much as 8000bp upstream of
the transcription start site has been shown to contain
regulatory activity in conventional CAT assays (18).
The 50-untranslated region (UTR) has also been impli-
cated to contain regulatory elements responsive to iron
(45), interleukin-1 (46) and TGF-b (47). In order to pre-
serve such regulation in germline transgenic ﬁsh derived
from these enhancer trap-modiﬁed BACs, the UE in our
enhancer trap transposons include the 147bp of this UTR
(Figure 1B).
Comparison of data in Figures 4 and 7–9, demonstrate
that the intron 1 enhancer identiﬁed here directs speciﬁc
expression of a GFP-reporter gene in two completely
diﬀerent tissues depending on whether APPb promoter
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APPb
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Figure 7. (A) Pattern of GFP ﬂuorescence observed with injecting DNA from Enhancer trap retroﬁtted BACs: transient expression patterns
produced by BACs 74D, 70D, 94C, 92C and 84C have an extensive network pattern of ﬂuorescence in the mid- and hind-brain regions
(indicated by white arrows) in addition to ﬂuorescence in the spinal chord that runs throughout the length of the ﬁsh. An enlarged view of a section
of the expression pattern with BAC 70D is shown immediately below the whole picture to emphasize the network pattern in the mid- and hind-
brain regions. Only neural expression is observed with these BACs along with BACs 80C through 75C, although the pattern is much simpler in
the latter set. Note the ﬂuorescence in the middorsal ganglia extending all the way covering the entire length of the ﬁsh in each of these BACs. These
are also indicated by the white arrows. There is no expression in the notochord in BACs 74D through 75C. (B) A schematic drawn to scale of
BAC deletions 74D through 29C is shown against the sequence contig containing the APPb gene as assembled in version ZFISH7. The enhancer
trap containing ends of deletions from BACs-C and -D are shown as colored triplets, and their locations were determined by sequencing with
transposon end-based primers. The locations of APPb, ASMT-like EST and NCAM2 genes are indicated on the sequence contig. Also indicated by
the double-edged arrow is the location of the enhancer in intron 1 of APPb. (C) Shows the strikingly diﬀerent pattern of GFP expression observed
with enhancer trap containing BACs 72C, 52C, 38C and 29C. Expression is exclusively in the notochord as shown by the white arrows.
(D) A table of numbers showing the distribution of ﬁsh expressing either in neurons (CNS) or cells of the notochord for each enhancer trap BAC
injected. These are out of 100 animals surviving till 72 hpf. The pictures here were taken between 60 and 72 hpf. Bright ﬁeld images for several
pictures shown here are included in Supplementary Figure 1.
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are adjacent to it. We conclude that the enhancer can
function speciﬁcally in nonneural tissue such as the noto-
chord when used with promoter proximal elements
within the +0.147 to  0.35kb of sequence surrounding
the transcription start site of APPb. However, this
promiscuity disappears and its function becomes
exquisitely speciﬁc to enhancing expression in neurons
when juxtaposed with additional promoter elements
located farther upstream till about  28kb of APPb. The
data also suggest that some type of transcription repres-
sion activity resides around  28kb that suppresses expres-
sion in the notochord, because simultaneous expression in
the notochord and neural cells is not observed in the same
ﬁsh using BAC deletions 74D through 75C
(Figure 7A). Once this upstream DNA extending till
 28kb is deleted, as in BACs 72C, 52C, 38C and
29C, reappearance of the notochord expression pattern
is observed (Figure 7C). Nevertheless, BACs 72C,
52C, 38C and 29C, serve as important controls to
show that the exclusive neural pattern observed with
BACs 74D through 75C is not merely a consequence
of the enhancer trap being in the BAC environment as
opposed to the small Tn-plasmid, but that far-upstream
promoter elements located within the  28kb DNA
upstream of the start site are required for neuron-speciﬁc
expression. The strikingly diﬀerent, yet speciﬁc, expression
patterns elicited by this enhancer when working in or out
of context of its own gene is unique to the best of our
knowledge.
Tissue-speciﬁc expression of the APPb gene resembling
its endogenous pattern (22) requires two separate, some-
what distant regulatory domains to cooperate in cis to
confer tissue-speciﬁcity. The two domains of regulation are
the  1kb of DNA within intron 1 (ZFISH7:9:29144733-
29145740), and the region +0.147 to  28kb upstream of
the gene. As indicated above in this report, exclusion of
the  1kb IE produced no expression of GFP: APPb
BAC-C deleted from the wild-type loxP end of insert
DNA with Tn-US (Figures 1B, C and 2) failed to express
GFP in any tissue (data not shown). Absence of the
+0.147 to  28kb region on the other hand leads to
expression in the inappropriate tissue, as seen with both
the set of Tn-plasmids Tn-10, Tn-13, Tn-3 and Tn-82
(Figure 4), and BACs 72C, 52C, 38C and 29C
(Figure 7C).
A search for transcription factor binding sites in the
 1kb intron enhancer sequence using bioinformatic
tools reveals a high likelihood for GATA 3 and SOX 5
recognition sites (Supplementary Figure 2). Although deﬁ-
nitive identiﬁcation of actual binding by these transcrip-
tion factor complexes to this enhancer region awaits
further studies, it is rather intriguing to note that GATA
3 and associated factors have been implicated in path-
ways guiding the aging process in C. elegans (48), and
involved also in allergic inﬂammation (49). SOX 5 has
been implicated, along with SOX 9, in the diﬀerentia-
tion and establishment of several cell lineages including
chondrocytes and glial cells of the nervous system in the
spinal chord (50). Binding sites for SOX 9 and other SRY-
related protein factors are also evident within the 1kb
intron enhancer sequence as indicated in Supplementary
Figure 2.
Results from both transient expressions (Figure 7), and
stable lines with BACs 84C and 94C (Figures 8 and 9),
suggests that upstream regulation of the APPb gene is
likely to extend much farther than the 8kb limit identiﬁed
for the primate APP earlier (18). Ends of BACs 94C
C A
D
B
Figure 8. Expression in F1 animals derived from germline transgenic
parents that were injected with DNA from BAC 94C are shown.
Strong ﬂuorescence from the yolk sac combined with low copy numbers
of integrated BAC presents hurdles to data collection. (A and B) Show
GFP ﬂuorescence in the lateral line (indicated by the pink arrows) in
the anterior and posterior portions of the same ﬁsh. (C) Shows the
ﬂuorescence in an embryo from a diﬀerent germline parent. (D)
Shows a control embryo that is GFP negative from a parent that
was positive in transient expression of GFP. The overall ﬂuorescence
is low in the control compared to those of GFP positive embryos under
identical conditions and, more importantly, never shows ﬂuorescence in
the lateral line. Pictures were recorded between 48 and 72 hpf.
A B
C
Figure 9. Expression in F1 animals derived from germline transgenic
parents that were injected with DNA from BAC 84C is shown. (A–C)
Shows GFP expression in the lateral line (indicated by the pink
arrows), and possibly in the dorsal root ganglion, visible just beneath
the extensive network pattern of ﬂuorescence on the surface.
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APPb transcription start site, respectively, and neural
expression from these clones in stable lines therefore
suggest that APPb-speciﬁc regulatory sequences exist at
locations beyond  24kb that, in conjunction with the
0.35kb UE and 1.2kb IE, can assemble productive
transcription initiation complexes speciﬁcally in neurons
to express GFP. The earlier determination that 8kb is
the limit of regulation by upstream sequences in primate
APP (18) appears unlikely; as we note that the zebraﬁsh
genome is compressed  4-fold with respect to that of
rhesus monkey.
The simpler pattern of expression with BAC deletions
80C through 75C (Figure 7A) might indicate that resi-
dual promoter elements required for neural cell-speciﬁc
expression are available till about 28kb upstream, and
these might prove suﬃcient to produce partial expression
patterns by recruitment of factors through protein–protein
interactions similar to those described earlier (51,52).
Importantly, there is no expression in the notochord
from these BACs.
The upstream regulatory regions identiﬁed here prob-
ably pertain to APPb only, and are unadulterated by those
from adjoining genes: the 200kb upstream of APPb has
only two other genes, one ASMT-like EST annotated
some 60kb away and another, NCAM2, located
 160kb from APPb (Figure 7B). Sequences downstream
of APPb intron 1 are deleted in all BACs during retro-
ﬁtting with enhancer traps.
Highlights of themethodology
The methodology described here uses BACs, and therefore
has all of the advantages associated with their use com-
pared to small plasmid constructs (53–60). Unlike the
other BAC recombineering approaches; however, our
strategy is ‘nontargeted’, and produces a large set of
DNA constructs rapidly to test for function of potential
regulatory elements without having to select sequences for
modiﬁcations. It is also not aﬀected by repetition of
sequences elsewhere in the chromosome. Subtractive
analysis from one or both ends (25), to decipher the role
of individual regulatory elements in a cluster, is also likely
to be easier using the enhancer trap BAC approach
described here.
In situations where function is conserved without
sequence similarity (8), choosing the correct sequence to
test might be a hit-or-miss phenomenon with a targeted
approach. Our methodology should prove most helpful
here since it acts more like a ‘mine-sweeper’ moving
along the BAC DNA; capable of identifying all regulatory
sequences upstream of a gene in an unbiased manner.
Functional comparisons between individual enhancer
trap BACs are thus more meaningful as the modiﬁcations
in each remain constant. While the Tol2 system can score
functional CNEs using zebraﬁsh rapidly (10); subtractive
analysis for exploring mechanisms of combinatorial inter-
play of multiple elements regulating a gene, similar to that
described here, would be tedious. The BAC enhancer trap
technology has three additional features that might
also prove beneﬁcial: (i) allows sampling much larger
DNA, and consequently multiple discontinuous regula-
tory domains simultaneously, (ii) the context of regulatory
DNA with respect to the gene and chromosome is pre-
served and (iii) can be used with BACs in established
libraries from a wide variety of organisms, and tested in
several species. Although the methodology does not allow
generation of internal deletions, truncations from the end
opposite to the enhancer trap can be made with a lox511
transposon to explore functions of candidate regulatory
regions in a limited way. Sequences bending DNA
(61–63), or phasing nucleosomes and other transcription
factors (64–66) are left unaltered using BACs compared to
characteristics of the gene region found endogenously.
Bringing exogenous pieces of DNA together to create
artiﬁcial joints in small plasmids to trans-activate reporter
genes do not adequately address the endogenous role of
the regulatory sequence, and this is avoided using BACs.
DNA structure surrounding regulatory factor binding
sites have evolved over long periods, and these are also
left unaltered here. We note there are 52 sites with six or
more A-residues, known to cause bends in unpackaged
DNA (62), in the 28-kb upstream regulatory sequence
identiﬁed here in APPb.
Trapping gene regulatory elements by random insertion
of a transposon containing reporter gene with minimal
promoter into the genomes of Drosophila (67,68), and
other vertebrates (11,69–73) has been very successful.
These approaches insert the enhancer trap, i.e. p-element,
retroviral vector or transposable element, directly into the
genome of the organism, with mapping of the sites of
integration done subsequently. BACs in contrast have
already been mapped on the chromosome.
The BAC enhancer trap methodology is amenable to
manipulation along several lines: GFP reporter in the
transposon can be replaced by clinically relevant mutant
cDNAs of the gene, such as the Swedish mutant form of
human APP (30), to create animal models for screening
small molecules to generate drug leads. Instead, toxigenes
replacing the GFP reporter could produce tools for cell
killing in speciﬁc tissue in transgenic animals.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We are grateful to Drs Ranjan Sen and TinChung Leung
for numerous helpful discussions. We thank Dr Deepak
Srivastava for the preliminary cross-species comparative
genome sequence analysis, and Cheryl Harrington,
Rosalind Grays, and Kathy Wulﬀ, for support and
encouragement. We also thank Dr Ju-Ahng Lee for show-
ing us zebraﬁsh injection procedures, and Shanta
Mackinnon from the Zebraﬁsh Core Facility for a
steady supply of eggs. P.K.C. gratefully acknowledges
the support and encouragement of former NCCU
Chancellor Dr James Ammons throughout the course of
this work.
6246 Nucleic Acids Research, 2008, Vol. 36, No. 19FUNDING
MBRS-SCORE (# SO 608049); NIGMS and EXPORT
(#1P20 MD00175-01); National Institute of Health;
North Carolina Biotechnology Center. Funding for open
access charge: National Institutes of Health-NCMH&HD.
Conﬂict of interest statement. None declared.
REFERENCES
1. Ahituv,N., Prabhakar,S., Poulin,F., Rubin,E.M. and Couronne,O.
(2005) Mapping cis-regulatory domains in the human genome using
multi-species conservation of synteny. Hum. Mol. Genet., 14,
3057–3063.
2. Ahituv,N., Rubin,E.M. and Nobrega,M.A. (2004) Exploiting
human–ﬁsh genome comparisons for deciphering gene regulation.
Hum. Mol. Genet., 13, R261–R266.
3. Dermitzakis,E.T., Reymond,A. and Antonarakis,S.E. (2005)
Conserved non-genic sequences–an unexpected feature of
mammalian genomes. Nat. Rev. Genet., 6, 151–157.
4. Shin,J.T., Priest,J.R., Ovcharenko,I., Ronco,A., Moore,R.K.,
Burns,C.G. and MacRae,C.A. (2005) Human-zebraﬁsh non-coding
conserved elements act in vivo to regulate transcription. Nucleic
Acids Res., 33, 5437–5445.
5. Woolfe,A., Goodson,M., Goode,D.K., Snell,P., McEwen,G.K.,
Vavouri,T., Smith,S.F., North,P., Callaway,H., Kelly,K. et al.
(2005) Highly conserved non-coding sequences are associated with
vertebrate development. PLoS Biol., 3, e7.
6. McEwen,G.K., Woolfe,A., Goode,D., Vavouri,T., Callaway,H. and
Elgar,G. (2006) Ancient duplicated conserved non-coding elements
in vertebrates: a genomic and functional analysis. Genome Res., 16,
451–465.
7. Xie,X., Kamal,M. and Lander,E.S. (2006) A family of conserved
noncoding elements derived from an ancient transposable element.
Proc. Natl Acad. Sci. USA, 103, 11659–11664.
8. Fisher,S., Grice,E.A., Vinton,R.M., Bessling,S.L. and
McCallion,A.S. (2006) Conservation of RET regulatory function
from human to zebraﬁsh without sequence similarity. Science, 14,
276–279.
9. Pennacchio,L.A., Ahituv,N., Moses,A.M., Prabhakar,S.,
Nobrega,M.A., Shoukry,M., Minovitsky,S., Dubchak,I., Holt,A.,
Lewis,K.D. et al. (2006) In vivo enhancer analysis of human
conserved non-coding sequences. Nature, 444, 499–502.
10. Fisher,S., Grice,E.A., Vinton,R.M., Bessling,S.L., Urasaki,A.,
Kawakami,K. and McCallion,A.S. (2006) Evaluating the biological
relevance of putative enhancers using Tol2 transposon-mediated
transgenesis in zebraﬁsh. Nat. Protocols, 1, 1297–1305.
11. Ellingsen,S., Laplante,M.A., Konig,M., Kikuta,H., Furmanek,T.,
Hoivik,E.A. and Becker,T.S. (2005) Large-scale enhancer detection
in the zebraﬁsh genome. Development, 132, 3799–3811.
12. Shizuya,H., Birren,B., Kim,U.J., Mancino,V., Slepak,T.,
Tachiiri,Y. and Simon,M. (1992) Cloning and stable maintenance
of 300-kilobase-pair fragments of human DNA in Escherichia coli
using an F-factor-based vector. Proc. Natl Acad. Sci. USA, 89,
8794–8797.
13. Ioannou,P.A., Amemiya,C.T., Garnes,J., Kroisel,P.M., Shizuya,H.,
Chen,C., Batzer,M.A. and de Jong,P.J. (1994) A new
bacteriophage P1-derived vector for the propagation of large human
DNA fragments. Nat. Genet., 6, 84–89.
14. Osoegawa,K., Mammoser,A.G., Wu,C., Frengen,E., Zeng,C.,
Catanese,J.J. and de Jong,P.J. (2001) A bacterial artiﬁcial chromo-
some library for sequencing the complete human genome. Genome
Res., 11, 483–496.
15. Salbaum,J.M., Weidemann,A., Lemaire,H.G., Masters,C.L. and
Beyreuther,K. (1988) The promoter of Alzheimer’s disease amyloid
A4 precursor gene. EMBO J., 7, 2807–2813.
16. Yoshikai,S.I., Sasaki,H., Dohura,K., Fururya,H. and Sakaki,Y.
(1990) Genomic organization of the human amyloid beta-protein
precursor gene. Gene, 87, 257–263.
17. Lahiri,D.K. and Robakis,N.K. (1991) The promoter activity of the
gene encoding Alzheimer beta-amyloid precursor protein (APP) is
regulated by two blocks of upstream sequences. Brain Res. Mol.
Brain Res., 9, 253–257.
18. Song,W. and Lahiri,D.K. (1998) Functional identiﬁcation of the
promoter of the gene encoding the Rhesus monkey beta-amyloid
precursor protein. Gene, 217, 165–176.
19. Lahiri,D.K., Song,W. and Ge,Y.W. (2000) Analysis of the
50-ﬂanking region of the beta-amyloid precursor protein gene that
contributes to increased promoter activity in diﬀerentiated neuronal
cells. Brain Res. Mol. Brain Res., 77, 185–198.
20. Richardson,J.C., Kendal,C.E., Anderson,R., Priest,F., Gower,E.,
Soden,P., Gray,R., Topps,S., Howlett,D.R., Lavender,D. et al.
(2003) Ultrastructural and behavioural changes precede amyloid
deposition in a transgenic model of Alzheimer’s disease.
Neuroscience, 122, 213–228.
21. Lahiri,D.K., Ge,Y.W. and Maloney,B. (2005) Characterization
of the APP proximal promoter and 50-untranslated regions:
identiﬁcation of cell-type speciﬁc domains and implications in
APP gene expression and Alzheimer’s disease. FASEB J., 19,
653–665.
22. Musa,A., Lehrach,H. and Russo,V.A. (2001) Distinct expression
patterns of two zebraﬁsh homologues of the human APP gene
during embryonic development. Dev. Genes Evol., 211, 563–567.
23. Erman,B. and Sen,R. (1996) Context dependent transactivation
domains activate the immunoglobulin mu heavy chain gene
enhancer. EMBO J., 15, 4665–4675.
24. Wozniak,R.J., Boyer,M.E., Grass,J.A., Lee,Y. and Bresnick,E.H.
(2007) Context dependent GATA factor function: combinatorial
requirements for transcriptional control in hematopoietic and
endothelial cells. J. Biol Chem., 282, 14665–14674.
25. Shakes,L.A., Garland,D.M., Srivastava,D.K., Harewood,K.R. and
Chatterjee,P.K. (2005) Minimal cross-recombination between wild
type and loxP511 sites in vivo facilitates truncating both ends of
large DNA inserts in pBACe3.6 and related vectors. Nucleic Acids
Res., 33, e118.
26. Chatterjee,P.K. (2004) Retroﬁtting BACs and PACs with LoxP
transposons to generate nested deletions. In Zhao,S. and
Stodolsky,M. (eds), Bacterial Artiﬁcial Chromosomes, Vol. 1.
The Humana Press Inc., Totowa, NJ, USA, pp. 231–241.
27. Chatterjee,P.K., Yarnall,D.P., Haneline,S.A., Godlevski,M.M.,
Thornber,S.J., Robinson,P.S., Davies,H.E., White,N.J., Riley,J.H.
and Shepherd,N.S. (1999) Direct sequencing of bacterial and P1
artiﬁcial chromosome nested-deletions for identifying position-
speciﬁc single nucleotide polymorphisms. Proc. Natl Acad. Sci.
USA, 96, 13276–13281.
28. Chatterjee,P.K. and Baker,J.C. Jr. (2004) Preparing nested deletions
template DNA for ﬁeld inversion gel electrophoresis analyses and
position-speciﬁc end sequencing with transposon primers. In
Zhao,S. and Stodolsky,M. (eds), Bacterial Artiﬁcial Chromosomes,
Vol. 1. The Humana Press Inc., Totowa, NJ, USA, pp. 243–254.
29. Dillen,K. and Annaert,W. (2006) A two decade contribution
of molecular cell biology to the centennial of Alzheimer’s
disease: are we progressing toward therapy? Int. Rev. Cytol., 254,
215–300.
30. Reaume,A.G., Howland,D.S., Trusko,S.P., Savage,M.J.,
Lang,D.M., Greenberg,B.D., Siman,R. and Scott,R.W. (1996)
Enhanced amyloidogenic processing of the beta-amyloid precursor
protein in gene-targeted mice bearing the Swedish familial
Alzheimer’s disease mutations and a ‘humanized’ Abeta sequence.
J. Biol. Chem., 271, 23380–23388.
31. Gilmore,R.C., Baker,J. Jr., Dempsey,S., Marchan,R.,
Corprew,R.N.L. Jr., Maeda,N., Smithies,O., Byrd,G.,
Bukoski,R.D., Harewood,K.R. et al. (2001) Using PAC nested-
deletions to order contigs and microsatellite markers at the high
repetitive sequence containing Npr3 gene locus. Gene, 275, 65–72.
32. Brake,R.L., Chatterjee,P.K., Kees,U.R. and Watt,P.M. (2004) The
functional mapping of long-range transcription control elements of
the HOX11 proto-oncogene. Biochem. Biophys. Res. Com., 313,
327–335.
33. Chi,X., Chatterjee,P.K., Wilson,W. III, Zhang,S.-X., DeMayo,F.
and Schwartz,R.J. (2005) Complex cardiac Nkx2-5 gene
expression activated by noggin sensitive enhancers followed by
chamber speciﬁc modules. Proc. Natl Acad. Sci. USA, 102,
13490–13495.
Nucleic Acids Research, 2008, Vol. 36, No. 19 624734. Banerji,J., Rusconi,S. and Schaﬀner,W. (1981) Expression of a beta-
globin gene is enhanced by remote SV40 DNA sequences. Cell, 27,
299–308.
35. Humphries,R.K., Ley,T., Turner,P., Moulton,A.D. and
Nienhuis,A.W. (1982) Diﬀerences in human alpha-, beta- and
delta-globin gene expression in monkey kidney cells. Cell, 30,
173–183.
36. Berg,P.E., Yu,J.K., Popovic,Z., Schumperli,D., Johansen,H.,
Rosenberg,M. and Anderson,W.F. (1983) Diﬀerential activation of
the mouse beta-globin promoter by enhancers. Mol. Cell. Biol., 3,
1246–1254.
37. Ameres,S.L., Drueppel,L., Pﬂeiderer,K., Schmidt,A., Hillen,W. and
Berens,C. (2005) Inducible DNA-loop formation blocks transcrip-
tional activation by an SV40 enhancer. EMBO J., 24, 358–367.
38. Zheng,R., Shen,R., Goodman,O.B. Jr. and Nanus,D.M. (2006)
Multiple androgen response elements cooperate in androgen regu-
lated activity of the type 1 neutral endopeptidase promoter.
Mol. Cell. Endocrinol., 259, 10–21.
39. Guo,X., Evans,T.R., Somanath,S., Armesilla,A.L., Darling,J.L.,
Schatzlein,A., Cassid,J. and Wang,W. (2007) In vitro evaluation of
cancer-speciﬁc NF-kappaB-CEA enhancer-promoter system for
5-ﬂuorouracil prodrug gene therapy in colon cancer cell lines.
Br. J. Cancer, 97, 745–754.
40. Pheasant,M. and Mattick,J.S. (2007) Raising the estimate of func-
tional human sequences. Genome Res., 17, 1245–1253.
41. Cooper,G.M. and Brown,C.D. (2008) Qualifying the relationship
between sequence conservation and molecular function. Genome
Res., 18, 201–205.
42. Way,J.C. and Kleckner,N. (1985) Transposition of plasmid-borne
Tn10 elements does not exhibit simple length-dependence. Genetics,
111, 705–713.
43. Mu ¨ ller,F., Chang,B., Albert,S., Fischer,N., Tora,L. and Stra ¨ hle,U.
(1999) Intronic enhancers control expression of zebraﬁsh sonic
hedgehog in ﬂoor plate and notochord. Development, 126,
2103–2116.
44. Pogoda,H.M., Sternheim,N., Lyons,D.A., Diamond,B.,
Hawkins,T.A., Woods,I.G., Bhatt,D.H., Franzini-Armstrong,C.,
Dominguez,C., Arana,N. et al. (2006) A genetic screen identiﬁes
genes essential for development of myelinated axons in zebraﬁsh.
Dev. Biol., 298, 118–131.
45. Rogers,J.T., Randall,J.D., Cahill,C.M., Eder,P.S., Huang,X.,
Gunshin,H., Leiter,L., McPhee,J., Sarang,S.S., Utsuki,T. et al.
(2002) An iron-responsive element type II in the 50-untranslated
region of the Alzheimer’s amyloid precursor protein transcript.
J. Biol. Chem., 277, 518–528.
46. Shaw,K.T., Utsuki,T., Rogers,J., Yu,Q.S., Sambamurti,K.,
Brossi,A., Ge,Y.W., Lahiri,D.K. and Greig,N.H. (2001) Phenserine
regulates translation of beta-amyloid precursor protein mRNA by a
putative interleukin-1 responsive element, a target for drug devel-
opment. Proc. Natl Acad. Sci. USA, 98, 7605–7610.
47. Maloney,B., Ge,Y.-W., Greig,N. and Lahiri,D.K. (2004) Presence
of a ‘CAGA box’ in the APP gene unique to amyloid plaque-
forming species and absent in all APP-1/2 genes: implications in
Alzheimer’s disease. FASEB J., 18, 1288–1290.
48. Budovskaya,Y.V., Wu,K., Southworth,L.K., Jiang,M., Tedesco,P.,
Johnson,T.E. and Kim,S.K. (2008) An elt-3/elt-5/elt-6 GATA
transcription circuit guides aging in C. elegans. Cell, 134, 291–303.
49. Barnes,P.J. (2008) Role of GATA-3 in Allergic Diseases. Curr. Mol.
Med., 8, 330–334.
50. Hattori,T., Coustry,F., Stephens,S., Eberspaecher,H., Takigawa,M.,
Yasuda,H. and de Crombrugghe,B. (2008) Transcriptional regula-
tion of chondrogenesis by coactivator Tip60 via chromatin asso-
ciation with Sox9 and Sox5. Nucleic Acids Res., 36, 3011–3024.
51. Kaufmann,J. and Smale,S.T. (1994) Direct recognition of initiator
elements by a component of the transcription factor IID complex.
Genes Dev., 8, 821–829.
52. Nikolajczyk,B.S., Dang,W. and Sen,R. (1999) Mechanisms of mu
enhancer regulation in B lymphocytes. Cold Spring Harb. Symp.
Quant. Biol., 64, 99–107.
53. Giraldo,P. and Montoliu,L. (2001) Size matters: use of YACs,
BACs and PACs in transgenic animals. Transgenic Res., 2, 83–103.
54. Yang,X.W., Model,P. and Heintz,N. (1997) Homologous recombi-
nation based modiﬁcation in Escherichia coli and germline
transmission in transgenic mice of a bacterial artiﬁcial chromosome.
Nat. Biotechnol., 9, 859–865.
55. Zhang,Y., Buchholz,F., Muyrers,J.P. and Stewart,A.F. (1998) A
new logic for DNA engineering using recombination in Escherichia
coli. Nat. Genet., 20, 123–128.
56. Jessen,J.R., Meng,A., McFarlane,R.J., Paw,B.H., Zon,L.I.,
Smith,G.R. and Lin,S. (1998) Modiﬁcation of bacterial artiﬁcial
chromosomes through chi-stimulated homologous recombination
and its application in zebraﬁsh transgenesis. Proc. Natl Acad. Sci.
USA, 95, 5121–5126.
57. Muyrers,J.P., Zhang,Y., Testa,G. and Stewart,A.F. (1999) Rapid
modiﬁcation of bacterial artiﬁcial chromosomes by ET recombina-
tion. Nucleic Acids Res., 27, 1555–1557.
58. Gong,S., Yang,X.W., Li,C. and Heintz,N. (2002) Highly eﬃcient
modiﬁcation of bacterial artiﬁcial chromosomes (BACs) using novel
shuttle vectors containing the R6Kgamma origin of replication.
Genome Res., 12, 1992–1998.
59. Warming,S., Costantino,N., Court,D.L., Jenkins,N.A. and
Copeland,N.G. (2005) Simple and highly eﬃcient BAC recombi-
neering using galK selection. Nucleic Acids Res., 33, e36.
60. Yang,Z., Jiang,H., Chachainasakul,T., Gong,S., Yang,X.W.,
Heintz,N. and Lin,S. (2006) Modiﬁed bacterial artiﬁcial chromo-
somes for zebraﬁsh transgenesis. Methods, 39, 183–188.
61. Fried,M.G. and Crothers,D.M. (1983) CAP and RNA polymerase
interactions with the lac promoter: binding stoichiometry and long
range eﬀects. Nucleic Acids Res., 11, 141–158.
62. Ulanovsky,L., Bodner,M., Trifonov,E.N. and Choder,M. (1986)
Curved DNA: design, synthesis, and circularization. Proc. Natl
Acad. Sci. USA, 83, 862–866.
63. Gartenberg,M.R., Ampe,C., Steitz,T.A. and Crothers,D.M. (1990)
Molecular characterization of the GCN4-DNA complex. Proc. Natl
Acad. Sci. USA, 87, 6034–6038.
64. Hebbar,P.B. and Archer,T.K. (2007) Chromatin-dependent coop-
erativity between site-speciﬁc transcription factors in vivo. J. Biol.
Chem., 282, 8284–8291.
65. Ganapathi,M., Singh,G.P., Sandhu,K.S., Brahmachari,S.K. and
Brahmachari,V. (2007) A whole genome analysis of 50 regulatory
regions of human genes for putative cis-acting modulators of
nucleosome positioning. Gene, 391, 242–251.
66. Hardy,S. and Shenk,T. (1989) E2F from adenovirus-infected cells
binds cooperatively to DNA containing two properly oriented and
spaced recognition sites. Mol. Cell Biol., 9, 4495–4506.
67. O’Kane,C.J. and Gehring,W.J. (1987) Detection in situ of genomic
regulatory elements in Drosophila. Proc. Natl Acad. Sci. USA, 84,
9123–9127.
68. Wilson,C., Pearson,R.K., Bellen,H.J., O’Kane,C.J., Grossniklaus,U.
and Gehring,W.J. (1989) P-element-mediated enhancer detection:
an eﬃcient method for isolating and characterizing
developmentally regulated genes in Drosophila. Genes Dev., 3,
1301–1313.
69. Balciunas,D., Davidson,A.E., Sivasubbu,S., Hermanson,S.B.,
Welle,Z. and Ekker,S.C. (2004) Enhancer trapping in zebraﬁsh
using the sleeping beauty transposon. BMC Genom., 5, 62.
70. Korn,R., Schoor,M., Neuhaus,H., Henseling,U., Soininen,R.,
Zachgo,J. and Gossler,A. (1992) Enhancer trap integrations in
mouse embryonic stem cells give rise to staining patterns in chi-
maeric embryos with a high frequency and detect endogenous genes.
Mech. Dev., 39, 95–109.
71. Burns,J.C., Friedmann,T., Driever,W., Burrascano,M. and Yee,J.K.
(1993) Vesicular stomatitis virus G glycoprotein pseudotyped ret-
roviral vectors: concentration to very high titer and eﬃcient gene
transfer into mammalian and nonmammalian cells. Proc. Natl Acad.
Sci. USA, 90, 8033–8037.
72. Lin,S., Gaiano,N., Culp,P., Burns,J.C., Friedmann,T., Yee,J.K. and
Hopkins,N. (1994) Integration and germ-line transmission of a
pseudotyped retroviral vector in zebraﬁsh. Science, 265, 666–669.
73. Grabher,C., Henrich,T., Sasado,T., Arenz,A., Wittbrodt,J. and
Furutani-Seiki,M. (2003) Transposon-mediated enhancer trapping
in medaka. Gene, 322, 57–66.
74. Chatterjee,P.K., Mukherjee,S., Shakes,L.A., Wilson,W. III,
Harewood,K.R. and Byrd,G. (2004) Selecting transpositions of a
markerless transposon using phage P1 headful packaging: new
transposons for functionally mapping long range regulatory
sequences in BACs. Anal. Biochem., 335, 305–315.
6248 Nucleic Acids Research, 2008, Vol. 36, No. 19